Choreo LLC boosted its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 57,526 shares of the company's stock after purchasing an additional 6,422 shares during the quarter. Choreo LLC's holdings in Procter & Gamble were worth $8,430,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. Mitchell Mcleod Pugh & Williams Inc. increased its holdings in Procter & Gamble by 1.1% in the 4th quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 24,189 shares of the company's stock worth $3,545,000 after buying an additional 265 shares in the last quarter. Mather Group LLC. increased its holdings in Procter & Gamble by 10.3% in the 4th quarter. Mather Group LLC. now owns 37,891 shares of the company's stock worth $5,553,000 after buying an additional 3,524 shares in the last quarter. Gilbert & Cook Inc. increased its holdings in Procter & Gamble by 7.7% in the 4th quarter. Gilbert & Cook Inc. now owns 17,215 shares of the company's stock worth $2,523,000 after buying an additional 1,237 shares in the last quarter. Capital Investment Counsel Inc increased its holdings in Procter & Gamble by 0.6% in the 4th quarter. Capital Investment Counsel Inc now owns 40,179 shares of the company's stock worth $5,888,000 after buying an additional 249 shares in the last quarter. Finally, Eagle Wealth Strategies LLC bought a new stake in Procter & Gamble in the 4th quarter worth about $366,000. Institutional investors own 65.77% of the company's stock.
Insiders Place Their Bets
In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the sale, the insider now owns 11,507 shares of the company's stock, valued at approximately $1,858,265.43. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, insider Balaji Purushothaman sold 28,369 shares of the business's stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company's stock, valued at approximately $1,858,265.43. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO R. Alexandra Keith sold 855 shares of the business's stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders have sold a total of 55,865 shares of company stock valued at $9,009,280 in the last quarter. 0.17% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
PG traded up $0.37 on Monday, hitting $161.66. 4,620,889 shares of the company's stock traded hands, compared to its average volume of 6,928,548. The company's 50 day simple moving average is $159.72 and its 200-day simple moving average is $153.78. The firm has a market cap of $381.54 billion, a price-to-earnings ratio of 26.42, a P/E/G ratio of 3.27 and a beta of 0.44. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.32. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm's quarterly revenue was up .6% on a year-over-year basis. During the same quarter last year, the company earned $1.37 EPS. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current year.
Procter & Gamble Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $1.0065 dividend. This is an increase from Procter & Gamble's previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.49%. Procter & Gamble's payout ratio is presently 65.85%.
Wall Street Analysts Forecast Growth
PG has been the subject of several research analyst reports. Wells Fargo & Company lifted their price objective on Procter & Gamble from $162.00 to $170.00 and gave the stock an "overweight" rating in a report on Wednesday, January 24th. Royal Bank of Canada raised their target price on Procter & Gamble from $156.00 to $157.00 and gave the stock a "sector perform" rating in a research report on Wednesday, January 24th. Barclays raised their target price on Procter & Gamble from $168.00 to $170.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 23rd. Jefferies Financial Group raised their target price on Procter & Gamble from $175.00 to $182.00 and gave the stock a "buy" rating in a research report on Monday, April 22nd. Finally, The Goldman Sachs Group initiated coverage on Procter & Gamble in a research report on Friday, March 1st. They issued a "neutral" rating and a $168.00 target price on the stock. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $169.76.
Read Our Latest Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
